A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma

Clinical trial NCT05341557 · RECRUITING

Trial details

NCT number: NCT05341557
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Lymphoma NSCLC HCC

Start date: 2022-08-29
Primary completion: 2026-12-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.